Archives
-
Pitavastatin (NK-104): In Vitro Workflow Guide
2026-09-18
Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for controlled cholesterol-biosynthesis assays and related cellular readouts. This guide covers preparation, QC, and troubleshooting for in vitro work; the supplied dossier does not validate clinical, animal, or disease-model use.
-
Hydroxytyrosol N2302 for Reliable Cell Assays
2026-09-17
This scenario-driven guide explains how Hydroxytyrosol SKU N2302 can improve the interpretability of cell viability, proliferation, cytotoxicity, and oxidative-stress experiments. It combines formulation data, solvent controls, preparation calculations, orthogonal readouts, and practical vendor-selection criteria for reproducible biomedical workflows.
-
LCN2, Ferroptosis, and SA-AKI via AMPK/SIRT3/FOXO3a
2026-09-17
The reference study identifies Lipocalin-2 (LCN2) as a promoter of renal ferroptosis in sepsis-associated acute kidney injury (SA-AKI) and links this effect to suppression of the AMPK/SIRT3/FOXO3a antioxidant pathway. Using CLP mice, LPS-stimulated HK-2 cells, genetic manipulation, and pathway rescue experiments, the authors provide a mechanistic framework for interpreting oxidative injury in SA-AKI while highlighting limitations that remain before clinical translation.
-
PPP1R3G–PP1γ Control RIPK1 Cell Death
2026-09-16
The reference study identifies PPP1R3G–PP1γ as a phosphatase module that removes inhibitory RIPK1 phosphorylation and enables RIPK1-dependent apoptosis and type I necroptosis. Its combination of sensitized genome-wide screening, genetic rescue, phosphorylation-site analysis, and mouse validation clarifies how TNF signaling switches from survival-associated complex I to inflammatory cell death.
-
Açaí Extracts: Hepatocyte Toxicity and Induction
2026-09-16
Raichura and colleagues developed a consumer-relevant in vitro framework to test whether açaí extracts damage human hepatocytes or induce drug-metabolizing enzymes and transporters. The extracts produced preparation-dependent, time- and dose-related cytotoxicity, but showed little evidence of CYP or transporter induction, helping separate hepatotoxicity from botanical–drug interaction mechanisms.
-
γH2AX DNA Damage Detection Kit for FLASH-RT
2026-09-15
Learn how to use γ-H2AX immunofluorescence to compare FLASH-RT, conventional radiotherapy, and nanoparticle-assisted treatment in a controlled DNA damage workflow. Practical protocol settings, assay controls, and troubleshooting guidance help convert nuclear foci into reproducible evidence for DNA repair, apoptosis, and genotoxicity studies.
-
N3-kethoxal: From Guanine Reactivity to R-Loop Insight
2026-09-15
N3-kethoxal enables covalent guanine labeling across RNA and accessible DNA. This article connects its click-compatible chemistry with R-loop biology and practical assay controls, offering a framework beyond routine structure mapping.
-
miR-24-3p–Sp1/PI3K Axis in Doxorubicin HF
2026-09-14
The reference study identifies miR-24-3p as a pathogenic regulator of doxorubicin-induced heart failure, linking its activity to suppression of the Sp1/PI3K signaling axis. By combining rat and H9c2 cardiomyocyte models with gain- and loss-of-function experiments, pathway inhibition, and dual-luciferase validation, the work provides a mechanistic framework for studying apoptosis and oxidative stress in myocardial injury.
-
5-Methyl-CTP for Translational mRNA Design
2026-09-14
5-Methyl-CTP can help researchers build more durable, translation-competent mRNA while preserving a disciplined link between IVT chemistry and biological performance. This article uses a dairy-cow mRNA vaccine study to define practical assay decisions, controls, and translational limits.
-
740 Y-P: PI 3-Kinase Activator Workflows
2026-09-13
740 Y-P is a cell-permeable PI 3-kinase activator for controlled PI3K/AKT pathway perturbation in trafficking, neuronal survival, and cancer research. This guide connects formulation, pathway readouts, mechanistic controls, and troubleshooting to findings from an inflammatory cartilage study.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-12
Hydroxychloroquine Sulfate provides an aqueous-compatible research reagent for probing autophagy pathway modulation and TLR7/9-associated immune responses in autoimmune disease research. It is best suited to short-term water-based workflows and should not be selected for DMSO- or ethanol-based stocks or long-term storage of prepared solutions.
-
Spiroplasma Entry and Cytoskeletal Dependence in S2 Cells
2026-09-11
Wei et al. establish a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris enters insect cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological disruption of actin filaments and microtubules reduces intracellular infection, providing a useful framework for dissecting cytoskeleton-dependent host–pathogen interactions.
-
Prednisone: From Lymphocyte Mechanism to Translation
2026-09-11
Prednisone is more than an immunosuppressive compound: it is a mechanism-defined tool for connecting lymphocyte cell-cycle control, IL-2 signaling, apoptosis, formulation discipline, and translational safety. This article shows how to build more interpretable Prednisone studies while drawing a methodological lesson from recent LC–MS/MS research on botanical digestion.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-09-10
This study identifies dorsal-striatal D2 medium spiny neurons as a cell-type-specific substrate for autistic-like self-grooming and digging after Neuroligin 1 loss. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the work connects D2-MSN hyperactivation with PKC-associated increases in excitability.
-
Hydroxytyrosol in Kidney Oxidative Stress Research
2026-09-10
Hydroxytyrosol offers a practical way to investigate oxidative stress modulation in renal injury models. This article translates nicotine–kidney disease evidence into assay design principles while defining the compound’s experimental value, controls, and limitations.